Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gengnianchun (GNC) is a Traditional Chinese Medicine (TCM) herbal formula specifically developed for the management of perimenopausal syndrome. Originally formulated by Professor Wang Cai-yuan at the Obstetrics and Gynecology Hospital of Fudan University, the recipe is composed of five primary herbs: *Radix Rehmanniae*, *Rhizoma Anemarrhenae*, *Cortex Phellodendri*, *Herba Epimedii*, and *Herba Leonuri*. GNC is designed to "tonify the kidney" and "clear heat" according to TCM principles. Pharmacologically, it acts as a phytoestrogen complex that modulates the hypothalamic-pituitary-ovarian (HPO) axis and interacts with estrogen receptors (ERα and ERβ). Clinical and preclinical studies suggest that GNC can alleviate vasomotor symptoms (hot flashes), improve mood and sleep disturbances, and provide osteoprotective effects without the adverse proliferative risks on the endometrium typically associated with conventional hormone replacement therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on gengnianchun.